Handmade quality · Free shipping over $75 · Explore the atelier

Laquinimod Catalog No.:M11360-2 Alda-1 administration leads to 2

SKU: 95484992342

4.3
USD80.00 USD125.00

Pay in 4 interest-free payments of $20.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Alda-1 administration leads to 2 and 10 differentially expressed proteins in the FCx and Hp of apoE−/− mice

CAS Number: 192705-79-6

InChiKey: HSPRASOZRZDELU-LMOVPXPDSA-N

Hongwei & Li

Cidofovir is an acyclic nucleoside phosphonate

Laquinimod Catalog No.:M11360-2 Alda-1 administration leads to 2Laquinimod, also known as, is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple sclerosis (MS). Laquinimod is the successor of Active Biotech's failed experimental immunomodulator linomide. Laquinimod seems to be able to reduce the MS disease activity on MRI. In 2011, Teva announced its clinical trials involving laquinimod had failed, being unable to significantly reduce

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products